Quince Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Quince Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Quince Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $559K, a 1065% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $559K +$511K +1065% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $554K +$444K +404% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $576K +$405K +237% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $385K +$94K +32.3% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $48K -$160K -76.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $110K -$218K -66.5% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $171K -$172K -50.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $291K -$874K -75% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $208K -$1.14M -84.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $328K -$1.17M -78.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $343K -$157K -31.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.17M +$491K +72.8% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $1.35M +$504K +59.4% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $1.5M +$810K +118% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $500K -$137K -21.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $674K +$49K +7.84% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $848K +$124K +17.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $686K -$137K -16.6% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $637K -$178K -21.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $625K Dec 31, 2019 10-K 2021-03-01
Q3 2019 $724K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $823K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $815K Mar 31, 2019 10-Q 2019-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.